Ibupirol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibupirol

What is Ibupirol? Definition and Pharmacological Class

Property Description
Active Ingredient Ibuprofen (INN)
Primary Forms Tablets, Capsules, Suspension, Gel
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General Purpose Symptomatic relief of pain, inflammation, and fever
Origin Synthetic (Propionic acid derivative)

Ibupirol is a medicinal preparation whose sole active ingredient is Ibuprofen, a compound defined as a common Nonsteroidal Anti-Inflammatory Drug (NSAID). This class of medicine is primarily used to relieve pain and reduce fever. This medication is a synthetic compound, specifically classified as a propionic acid derivative, and is generally manufactured as a single-ingredient product (monotherapy).


The inclusion of Ibuprofen within the NSAID class establishes its primary pharmacological role, distinguishing it as a major category of synthetic drug known to address symptoms stemming from inflammation. Ibuprofen is often positioned as an accessible Over-the-Counter (OTC) solution, making it readily available for managing acute symptoms like a sudden headache or muscle soreness. Ibuprofen is characterized as a first-line agent for its triple-action properties.


Composition, Forms, and General Therapeutic Purpose

Ibupirol is commonly available in multiple delivery systems to provide versatile relief, including oral forms such as tablets, capsules, and suspensions (often aimed at pediatric patients), as well as alternative routes like topical gels and rectal suppositories. The product's composition is characterized by the active ingredient Ibuprofen combined with various inert bases or excipients required for stability and safe delivery, such as solid compounds for oral tablets or aqueous vehicles for liquid preparations.


The general therapeutic purpose of Ibupirol is to offer comprehensive symptomatic relief by providing a triple action: acting as an analgesic (to relieve pain), an antipyretic (to reduce fever), and an anti-inflammatory agent (to mitigate swelling). This core versatility makes it an established product, clinically recognized for managing common discomforts where an inflammatory component is present, such as in cases of general body aches or mild joint discomfort.

Regulatory References

  1. by the National Institutes of Health (NIH)

What side effects are possible with Ibupirol?

Possible side effects and safety information

Ibupirol, which contains Ibuprofen, carries an officially documented profile of potential adverse reactions, primarily classified by their effect on specific body systems in regulatory documents.

Systemic Safety Patterns and Serious Adverse Reactions

Treatment with NSAIDs, including Ibupirol, is associated with a reported increased risk of serious cardiovascular thrombotic events such as myocardial infarction (heart attack) and stroke, which can be fatal. This risk may be heightened with the duration of use and is more pronounced at high daily doses (typically 2400 mg/day). Another significant concern is the risk of serious gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation, which can occur at any time during treatment and may be fatal. The risk of such events is higher with prolonged duration of use.

Adverse Reaction Classification by System

Adverse effects involving the Gastrointestinal Disorders system are commonly reported. These include Uncommon occurrences of abdominal pain, nausea, and dyspepsia (indigestion), while diarrhoea and constipation are Rare. In the Nervous System Disorders class, headache is an Uncommon side effect, and aseptic meningitis is a Very Rare documented event.

Safety Considerations for Special Populations

Official regulatory information highlights safety concerns for specific populations. Older adults are at a higher risk of adverse reactions, especially fatal GI events. Use is generally avoided in patients at or after 20 weeks of gestation due to the potential for fetal renal dysfunction leading to low amniotic fluid (oligohydramnios).

The official labeling states that the medicine may mask the signs and symptoms of an underlying infection.

Overdose and Emergency Response

Ibupirol Overdose and When to Seek Help

Immediate medical attention is required for any suspected overdose of Ibupirol. Regulatory authorities mandate that you contact emergency services or a Poison Control Center right away, without delay, even if symptoms have not yet begun. Taking the medicine container or label to the emergency room is required.

Officially documented overdose manifestations can affect several bodily systems. Common initial signs include nausea, vomiting, abdominal pain, drowsiness, severe headache, dizziness, and confusion. Central Nervous System (CNS) effects can escalate in severity, potentially leading to seizures or a coma. Sensory manifestations like ringing in the ears (tinnitus) and blurred vision are also documented.

The official prescribing information highlights potentially life-threatening outcomes, including severe gastrointestinal bleeding, ulceration, and organ damage such as acute renal failure or liver failure. Serious cardiovascular and respiratory effects documented are low blood pressure (hypotension) and breathing difficulties (apnoea). Overdose in children has been specifically noted for potential CNS depression and transient renal failure.

Management is primarily supportive because no specific antidote is available for Ibuprofen overdose. Supportive measures described in regulatory texts include the administration of activated charcoal, intravenous fluids, and continuous monitoring of vital signs to manage complications like metabolic acidosis or circulatory shock.

Therapeutic Uses of Ibupirol

What Ibupirol Treats: Main Uses and Benefits

Ibupirol is used for symptomatic relief across domains involving physical discomfort, inflammation, and fever, helping patients manage episodes that disrupt daily stability. It offers supportive therapeutic benefit by moderating distressing symptoms across a range of conditions.

This medication is categorized for use within clinical settings that involve acute or disruptive symptom patterns, and contributes to easing the overall symptom load.

Ibupirol is commonly used to help with groups of symptoms that may appear suddenly, such as headaches, dental pain, pain from sprains and strains, backache, and the aches associated with the common cold and flu. It is also relevant in conditions involving recurrent or episodic manifestations like menstrual cramps (dysmenorrhea) and chronic inflammatory discomforts seen in rheumatoid arthritis or osteoarthritis.


Quick Fact: Key Use

The medication is applied in scenarios where short-term symptomatic assistance is needed, providing supportive relief when symptoms interfere with routine activities and helping to reduce the discomfort from inflammation and fever.

Regulatory References

  1. NIH MedlinePlus overview on Ibuprofen

Eligibility and Restrictions for Use

Who Can and Cannot Use Ibupirol?

The population eligibility for Ibupirol (Ibuprofen, an NSAID) is strictly governed by regulatory documentation, establishing formal prohibitions and conditional use requirements.

Populations for Whom Use is Contraindicated

Ibupirol must not be used by individuals who meet the following official exclusion criteria:

  • Patients with a known hypersensitivity or severe allergic reaction (such as asthma, urticaria, or anaphylaxis) to ibuprofen, aspirin, or any other NSAID.
  • Individuals in the setting of Coronary Artery Bypass Graft (CABG) surgery (immediately before or after).
  • Patients with severe renal, hepatic, or heart failure (NYHA Class IV).
  • Individuals with active gastrointestinal bleeding, peptic ulceration, or certain coagulation defects.
  • Women who are in the last trimester of pregnancy (after 20 weeks gestation).

Age and Condition-Based Restrictions

Population Group Eligibility Status (Official Labeling)
Infants Generally not recommended for children under 6 months of age; minimum age requirements vary by product formulation.
Older Adults (Age 60+) Use carries a higher risk of serious adverse events, particularly stomach bleeding and heart or kidney issues.
Cardiovascular Risk Use in patients with uncontrolled hypertension, established heart disease, or fluid retention requires careful consideration from a prescriber.
Lactation Generally considered acceptable for use during breastfeeding as the concentration in breast milk is very low.

Official regulatory documents define these eligibility constraints through mandatory contraindication and warning statements, ensuring the medication is not used when specific, documented high-risk factors are present.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Ibupirol, an NSAID, is defined by government regulatory documents to identify pharmacokinetic and pharmacodynamic constraints. These co-administration rules are based strictly on official labeling.

Interaction Type Interacting Substances/Classes Constraint Description
Contraindicated Other NSAIDs (including COX-2 inhibitors) Prohibition due to heightened risk of serious gastrointestinal adverse events, as specified in regulatory labels.
Exposure Alteration Lithium, Digoxin, Methotrexate Officially documented to increase plasma concentrations of these substances by reducing their renal clearance.
Pharmacodynamic Anticoagulants, SSRIs, Corticosteroids Additive risk of serious outcomes, particularly gastrointestinal bleeding, and reduction of efficacy for antihypertensive agents.

Timing and Substance-Specific Constraints:

  • Low-Dose Aspirin: Ibupirol must be administered at least eight hours before or at least 30 minutes after immediate-release low-dose Acetylsalicylic Acid to avoid interference with the antiplatelet effect.
  • Metabolic Inhibitors: Co-administration with CYP2C9 Inhibitors is documented to increase Ibupirol exposure (plasma levels).
  • Alcohol/Herbal Products: Use with Alcohol or the herbal product Ginkgo Biloba is officially noted to increase the risk of bleeding.
  • Population Note: The severity of these interactions is often noted as being greater in elderly patients and those with pre-existing renal or hepatic impairment.

This structure reflects the regulatory documentation by classifying interactions by severity, mechanism, and required separation, providing a neutral, complete overview of the official label constraints.

Mechanism of Action

Ibupirol is a non-steroidal agent that functions primarily as a non-selective, reversible inhibitor of the cyclooxygenase (COX) enzyme isoforms, COX-1 and COX-2 (also known as prostaglandin endoperoxide synthases 1 and 2, PTGS1 and PTGS2). The S-enantiomer is considered the more active pharmacological agent.

The molecular target is the arachidonic acid cascade. COX-1 and COX-2 catalyze the initial two-step conversion of the precursor arachidonic acid (released from membrane phospholipids) into prostaglandin H2 ( PGH2). Ibupirol binding to the active site impedes this dioxygenase and hydroperoxidase activity.

The intracellular consequence is a significant attenuation of prostanoid synthesis. PGH2 is the direct precursor for all downstream bioactive lipid mediators, including prostaglandins ( PGE2, PGI2), and thromboxane A2 ( TxA2).

The system-level physiological consequence of this enzyme inhibition is the modulation of cellular signaling mediated by these eicosanoids, particularly by reducing PGE2 levels in various tissues, including the central nervous system, and by inhibiting platelet TxA2 production.

Dosage and Administration Information

How to Use Ibupirol

Ibupirol (Ibuprofen) is administered according to standardized protocols, focusing on the route, precise dosing, and time-based administration constraints. The methods include oral intake (as tablets, capsules, or suspension) and intravenous (IV) injection, which is typically reserved for supervised clinical settings.


Official Dosing and Frequency

Administration follows a pattern of using the lowest effective dose for the shortest duration necessary. Adult prescription dosing generally involves a range of 400 mg to 800 mg per dose, with a maximum limit of 3200 mg over a 24-hour period. Non-prescription use is limited to a lower maximum daily quantity, such as 1200 mg.

Frequencies are defined, typically requiring a period of four to eight hours between doses. If a dose is missed, standard instructions involve taking it as soon as it is remembered, unless it is close to the next scheduled administration, at which point the missed dose should be skipped to prevent exceeding the daily limit.


Administration Conditions and Special Populations

Oral forms may be taken with food or milk to aid gastrointestinal tolerance, although taking them without food can expedite the rate of absorption. For IV administration, the solution requires dilution and must be infused over a specified minimum duration, such as 30 minutes for adult patients.

Dosage adjustments are outlined for certain groups. Pediatric patients require dosing based on body weight (mg/kg/dose). Furthermore, patients with significantly impaired organ function (hepatic or renal) may require dose reduction and close monitoring, reflecting established use constraints.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ibupirol

Ibupirol, which contains the active ingredient Ibuprofen, has been the subject of extensive scientific review and multiple types of studies, focusing on research exploring outcomes related to certain common symptoms. The evidence base is frequently reviewed by health authorities to understand what the research describes and where limitations exist.


Evidence for Use in Acute, Mild-to-Moderate Pain

The research base for Ibupirol was established through studies examining short-term changes in patient-reported physical discomfort, based mainly on Randomized Controlled Trials (RCTs). These studies are generally considered high-quality research designs, and were applied in studies examining patient-reported experiences related to physical discomfort from conditions associated with acute or disruptive episodes, such as headaches, dental pain following procedures, and pain from common musculoskeletal injuries or menstrual cramps. Research examined how symptoms change over time and what outcomes were related to physical discomfort.

Studies explored the outcomes over short, defined time intervals, monitoring outcomes related to physical discomfort. Findings describe patterns observed in the studies that were related to measured outcomes related to pain intensity. The evidence contributes to understanding symptom patterns during periods of heightened symptom activity, which often lasts for only a few hours. However, the majority of this evidence is limited to short-term observation periods.


Evidence for Symptom Pattern Evaluation of Chronic Inflammation

For conditions involving periods of heightened symptoms and functional limitations, such as osteoarthritis and rheumatoid arthritis, Ibupirol was studied in research exploring symptom pattern evaluation over defined time intervals. The research in this area includes medium-term RCTs alongside observational studies that evaluate daily-life functioning for patients with these conditions.

Trials documented measured changes in functional scales (such as joint stiffness) over the observation period. The evidence described patterns observed in studies over periods of several weeks or months. Data show patterns related to outcomes linked to inflammatory or irritative states. What remains uncertain is the full picture of the drug’s role in the long-term context of the disease. Long-term effects are not fully established, as the duration of many research trials focused on symptom endpoints.


Research Gaps and Areas of Uncertainty

A review of the evidence highlights several key limitations in the current research base. The follow-up durations were limited in many studies, restricting conclusions about the outcomes of repeated, long-term use. Furthermore, data for certain groups remain insufficient, meaning the available research does not determine whether an individual outside the primary study populations will respond similarly. These factors indicate that certainty remains low in specific areas, and research is ongoing to address these uncertainties.

Key Studies & References Ibuprofen for acute pain in adults

Frequently Asked Questions (FAQ)

Common questions about Ibupirol (FAQ)

Q: Are there any major food or drink restrictions while taking Ibupirol?

A: Official documentation notes that combining Ibupirol with alcohol increases the risk of bleeding in the stomach. Similarly, the herbal product Ginkgo Biloba is documented to increase this risk. Official guidance permits the medication to be taken with food or milk, which may help with stomach tolerance.

Q: Does Ibupirol interact with common decongestant medications?

A: Ibupirol is classified as a nonsteroidal anti-inflammatory drug (NSAID) and carries a documented risk of serious cardiovascular events. Some common decongestant medicines are known to affect blood pressure and heart rate. Official information indicates that co-administration of these classes requires cautious consideration due to the potential for combined cardiovascular effects.

Q: How can I check if Ibupirol has a known interaction with another medicine I am taking?

A: Public health guidance advises that you should always read the drug’s patient information leaflet and official label for a list of known interactions. Consulting a pharmacist or doctor is a standard step for verifying potential interactions.

Q: What information is publicly available about the safety profile of Ibupirol?

A: Complete safety information is made publicly available by regulatory bodies. This includes details on warnings, contraindications (reasons not to use the drug), and possible side effects. You can find this detailed profile in official drug label databases and patient information provided by government health institutions.

Q: Does Ibupirol have a risk of addiction or dependence?

A: Ibupirol is not an opioid and does not carry the risk of traditional addiction. However, official patient education notes that prolonged or excessive use may lead to a pattern of physical dependence. This is sometimes characterized by rebound symptoms, such as an increase in the pain it was taken to treat.

Q: Is it safe to drive or operate machinery after taking Ibupirol?

A: Official patient information generally indicates that the medication will not usually affect a person’s ability to drive or use machinery. However, the safety profile includes the possible side effect of dizziness. If a person experiences dizziness, it is recommended that individuals refrain from driving or operating machinery until the dizziness has stopped.

Q: Is Ibupirol generally considered safe for long-term use?

A: Regulatory guidance states that Ibupirol should be used for the shortest duration necessary to minimize potential risks. Non-prescription use has a specific time limit (e.g., 3 to 10 days, depending on the country) and exceeding it warrants consultation with a healthcare professional. Prolonged use carries an increased risk of serious gastrointestinal and cardiovascular events.

Q: Is Ibupirol an over-the-counter medicine or prescription-only?

A: Ibupirol (Ibuprofen) is available in two classifications: as an Over-the-Counter (OTC) medication at lower dosages, and as a prescription-only medication at higher dosages. The maximum daily limit is significantly lower for OTC products compared to prescription-strength products.

Q: Can children or teenagers take Ibupirol?

A: Official labels include specific pediatric dosing instructions based on the child’s body weight. This is generally for children aged 6 months and older, though minimum age requirements can vary by the specific product formulation. The application of Ibupirol in children and teenagers is governed by official product information and dosage requirements.

Q: How is Ibupirol eliminated from the body?

A: Ibupirol is processed (metabolized) mainly by the liver. Its resulting inactive breakdown products (metabolites) are primarily eliminated from the body through the urine, as detailed in official pharmacokinetic properties.

Q: Does Ibupirol cause drowsiness or fatigue?

A: While drowsiness and fatigue are not consistently listed as common reactions, official safety profiles do list side effects that affect the central nervous system, such as dizziness. The potential for dizziness suggests caution regarding impaired alertness.

Q: How long do the effects of Ibupirol last?

A: The expected duration of the medicinal effect is reflected by the recommended dosing frequency. Official labeling typically advises taking a dose every 4 to 6 hours as needed for symptom relief.

Q: Does Ibupirol affect the liver or kidneys?

A: Yes, regulatory information warns that Ibupirol can affect both organs. It is contraindicated (prohibited) in cases of severe liver and kidney failure. Official warnings note the potential for transient elevation of liver enzymes and a risk of kidney issues, especially in vulnerable populations.

Q: What is the purpose of Ibupirol, specifically?

A: Ibupirol is officially indicated for its triple-action properties to provide symptomatic relief. It is described as an analgesic (pain relief), an antipyretic (fever reduction), and an anti-inflammatory agent (mitigating swelling).

Q: Is there a generic version of Ibupirol available?

A: Yes, the single active ingredient in Ibupirol is Ibuprofen, which is the non-proprietary (generic) name for the drug. Ibuprofen is widely available as a generic product and under numerous brand names.

Q: Does Ibupirol show up on drug tests?

A: Medical literature has documented occasional reports where Ibuprofen resulted in a false positive test result on certain drug screens, specifically for the barbiturate class. This is a possibility that regulatory research has noted.

Q: Are there different strengths or forms of Ibupirol?

A: Yes, the official label confirms that Ibupirol is produced in various forms (including tablets, capsules, suspension, and IV solution) and multiple strengths. This variety is intended to accommodate different patient needs and administration routes.

Q: Is it possible to develop a tolerance to Ibupirol?

A: Official patient education discusses tolerance in the context of overuse. Individuals who take the medication excessively may notice that they require increasing amounts to achieve the same level of pain relief.

Q: What happens if Ibupirol is taken with alcohol?

A: Official warnings state that drinking three or more alcoholic drinks every day while using Ibupirol significantly increases the chance of serious side effects. The most emphasized risk is serious stomach bleeding.

Q: Does Ibupirol affect sleep patterns?

A: Scientific studies have investigated the drug’s working mechanism. Ibupirol inhibits substances like prostaglandins that are involved in body temperature regulation and melatonin synthesis, two biological processes that can influence sleep patterns.

Q: Is Ibupirol commonly used for fever reduction?

A: Yes, Ibupirol is officially classified as an antipyretic agent, meaning it reduces fever. It is one of the most common over-the-counter medications used for fever reduction in various age groups.

Q: Are there any warnings for people with asthma who use Ibupirol?

A: Official warnings specifically advise caution for patients with pre-existing asthma. If a patient has a known aspirin sensitivity, taking Ibupirol can potentially trigger bronchospasm, which is a sudden narrowing of the airways.

Q: What does 'contraindication' mean in relation to Ibupirol?

A: A contraindication is a feature of a patient’s health or medical history—such as a specific condition, symptom, or allergy—that makes it prohibited for them to take Ibupirol. This is because the treatment may cause harm when that specific factor is present.

Q: Can people with diabetes safely take Ibupirol?

A: The official label notes that use requires careful consideration, particularly for individuals with pre-existing conditions that affect the kidneys, which can be associated with diabetes. Caution is also advised due to possible drug interactions that may affect blood sugar levels.

Q: Does official documentation describe any specific limitations for how long Ibupirol should be used?

A: Yes, regulatory guidance explicitly states that the medication should be used for the shortest duration necessary to minimize potential risks. Non-prescription products have specific duration limits (e.g., 3 or 10 days, depending on the region) detailed on the packaging.

Q: What are the general expectations regarding improvement when taking Ibupirol?

A: For acute symptoms, the expected relief period is implied by the recommended dosing frequency (every 4–6 hours). For chronic inflammatory conditions, studies used for approval describe that a therapeutic response is often observed within approximately two weeks of consistent administration.

Q: Can I stop taking Ibupirol suddenly?

A: For routine, short-term use, official documentation does not indicate a specific risk of harm from immediate cessation. However, if the medication has been used excessively or for prolonged periods, stopping suddenly may lead to the return of symptoms or result in rebound headaches.

Q: Do clinical trials of Ibupirol include diverse patient populations?

A: Regulatory documents acknowledge limitations in the existing research base. Official reports state that data for certain patient groups or populations remain insufficient, indicating that not all groups were fully represented in the studies used for drug approval.

How should Ibupirol be stored and disposed of?

How to Store and Dispose of Ibupirol?

Ibupirol (Ibuprofen) must be stored strictly according to regulatory guidelines to ensure stability and safety.

Storage Requirements

Detail Requirement
Temperature Store at controlled room temperature (20 C to 25 C).
Protection Protect from moisture and light; avoid excessive heat.
Container Keep in the original container and keep it tightly closed.

Handling and Disposal

It is mandatory to keep this product out of the sight and reach of children.

Unused or expired Ibupirol must be disposed of according to local regulations. Regulatory guidance often specifies that medication should not be disposed of via wastewater or household waste to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibupirol found in:

A-Z Index: